Anticipatory Medicines in Dementia End of Life Care: Storage, Administration, Records and Out-of-Hours Safety

January 23, 2026

Anticipatory medicines can make a decisive difference to comfort at end of life in dementia, particularly out of hours when access to clinicians is slower and families are most anxious. However, they only improve outcomes when the service has robust processes for storage, authorisation, administration, documentation and review. This article sits within End of life care and advance care planning and should align with dementia service models so medicines practice, escalation routes and governance are consistent across settings.

What “anticipatory medicines” mean in operational terms

In dementia end of life care, anticipatory medicines are typically prescribed in advance for common symptoms that can escalate quickly: pain, agitation, nausea/vomiting, respiratory secretions and breathlessness. The operational aim is not “more medication”. It is timely symptom relief using lawful prescribing and competent administration, with clear thresholds and records that show why an intervention was necessary.

The main failure points are predictable: medicines are present but staff are unsure when to use them; documentation is weak; out-of-hours escalation is unclear; or governance does not pick up practice drift.

Pre-conditions for safe use

Clear authorisation and escalation routes

Staff must understand what they can do independently and what requires clinical advice. A practical approach is to build an “authorisation map” into the care plan and medicines protocol:

Prescriber authority: the medicines must be prescribed for the person, with clear directions and review arrangements.
Administration authority: only staff with the right training and competency can administer, following local policy.
Escalation triggers: defined thresholds for contacting GP/out-of-hours/palliative team (e.g., uncontrolled pain after agreed steps, repeated dosing within a defined timeframe, new symptoms that do not match the plan).

Without these, staff either delay medication (distress escalates) or administer defensively without sufficient clinical context.

Storage, access and controlled drugs discipline

Anticipatory medicines often include controlled drugs. The service must be able to show:

secure storage: compliant cabinets, restricted access and key control
stock control: clear records of receipt, use and disposal, including checks at set intervals
access arrangements: how medicines are accessed safely out of hours without unsafe workarounds

This is where governance matters: good practice is repeatable; unsafe practice is often a one-off that becomes normal.

Competency-based administration and documentation

End of life medicine administration requires more than “meds training”. Teams need competency checks focused on:

recognising pain and distress in dementia (including non-verbal cues)
recording observable symptoms and response to intervention
understanding side effects and when to escalate
accurate MAR chart completion and narrative notes that link symptom, action and outcome

Good records protect the person (and the service) because they show that medication use was proportionate, monitored and effective.

Day-to-day practice: what staff should record

To be defensible, notes must go beyond “appeared comfortable”. Practical recording should include:

trigger: what was observed (grimacing, guarding, restlessness, breathlessness cues, vocalisation, changes in tone)
context: what was happening (repositioning, personal care, evening sundowning pattern, after a fall)
non-pharmacological actions first where appropriate: reassurance, environment change, positioning, mouth care
medicine administered: dose, route, time (as per MAR) and any checks performed
response: what changed and when (settled within 20 minutes; breathing eased; distress reduced)
escalation: if not effective, who was contacted and what advice was given

This creates a clear narrative: problem, action, outcome, learning.

Operational Example 1: Night-time agitation managed safely without crisis escalation

Context: A person with advanced dementia becomes increasingly agitated at night, calling out, pulling at bedding and attempting to get up despite frailty. Family have previously asked staff to “call an ambulance if it happens again”.

Support approach: The care plan includes a symptom management routine and anticipatory medicines for agitation/pain, with clear thresholds for escalation. Staff implement reassurance and comfort measures first, then use prescribed medication when distress persists and matches the plan.

Day-to-day delivery detail: Staff reduce noise/light, offer a calm presence, check for pain triggers (positioning, continence needs), and document observed cues. When distress remains high, a competent staff member administers the prescribed medication, records dose/time on the MAR, and documents response at agreed intervals (e.g., 15–30 minutes). If distress does not reduce after the defined threshold, staff contact out-of-hours clinicians with a structured summary.

How effectiveness or change is evidenced: Evidence includes reduced prolonged distress episodes, fewer ambulance calls, consistent night logs showing symptom-response patterns, and clear records that demonstrate proportional use and monitoring.

Operational Example 2: Breathlessness and secretions managed with clear escalation thresholds

Context: A person develops noisy breathing and visible breathlessness cues. Staff are uncertain whether medication is appropriate and fear family will interpret it as “hastening death”.

Support approach: The service uses a shared communication statement within the end of life plan explaining symptom relief aims, and anticipatory medicines are prescribed for secretions/breathlessness with review triggers.

Day-to-day delivery detail: Staff reposition the person, ensure mouth care and comfort, reduce stimuli, and explain to family that the aim is comfort. A competent staff member administers prescribed medication when symptoms meet criteria, records the rationale and observed response, and monitors for side effects. Escalation is triggered if symptoms persist beyond the agreed threshold or if new symptoms appear.

How effectiveness or change is evidenced: Evidence includes reduced distress cues, fewer panicked family calls, consistent documentation linking symptom to intervention, and case review notes showing learning.

Operational Example 3: Governance prevents “workaround culture” with controlled drugs

Context: A service experiences staffing changes and begins to rely on informal practices for key access and stock checks, increasing the risk of error or allegation.

Support approach: The registered manager introduces a clear controlled drugs protocol: key control rules, double-check requirements, stock reconciliation frequency, and escalation routes when issues arise.

Day-to-day delivery detail: Staff complete checks at set times, record discrepancies immediately, and escalate to the manager/on-call. Competency checks are refreshed, and any administration outside routine prompts a brief reflective note: symptom, action, outcome and whether plan needs review.

How effectiveness or change is evidenced: Evidence includes audit compliance, reduced discrepancies, improved staff confidence, and governance minutes showing proactive oversight rather than reactive problem-solving.

Expectations to evidence

Commissioner expectation

Commissioners expect end of life symptom management to reduce avoidable distress and emergency escalation: clear protocols, timely access to appropriate medicines, competent administration, robust documentation, and audit trails that demonstrate safe practice out of hours.

Regulator / Inspector expectation (CQC)

CQC will look for safe medicines management and person-centred end of life care: staff competency, accurate MAR and controlled drugs records, clear escalation when symptoms are not controlled, and leadership oversight that audits, reviews incidents and improves practice.

Governance controls that keep anticipatory medicines safe

To prevent drift, services should be able to show routine assurance activity:

Monthly medicines audit: MAR accuracy, PRN use rationale, and response documentation quality.
Controlled drugs checks: reconciliation, key control discipline and discrepancy escalation logs.
Case-based learning: review a sample of end of life episodes to confirm escalation matched the plan.
Competency refresh: targeted refreshers on recognising distress in dementia and recording symptom-response evidence.

When these controls are embedded, anticipatory medicines become a reliable comfort safeguard rather than a risk area.